Safety in Numbers Drives Canopy Growth Corp. Higher

New research data provides Canopy Growth Corp. (TSX:CGC) stock with further momentum heading into the second half of January.

| More on:

Investors in Canopy Growth Corp. (TSX:CGC) and other publicly traded marijuana businesses in both Canada and the U.S. are only too aware of the growth potential of legal cannabis.

It’s huge.

U.S. estimates by investment bank Cowen and Company suggest cannabis sales will increase at a compound annual growth rate of 23% over the next decade to US$50 billion. In Canada, it’s estimated that 5.2 million Canadians will consume legalized pot annually by 2021.

As Canada moves towards legalizing the recreational use of marijuana, expected sometime in 2019, the U.S. federal government continues to drag its heels on the subject, despite the fact there are now 28 states with legalized medical marijuana and eight where weed is legal recreationally for those 21 or older.

Jeff Sessions, Donald Trump’s nominee for attorney general, is absolutely opposed to marijuana, suggesting in an April 2016 senate hearing that traffic fatalities in some states where marijuana was legal were up by 20%. Data from Colorado’s experience, according to FactCheck.org, suggests marijuana-related traffic deaths, hospital visits, and school suspensions have definitely increased since marijuana was legalized for recreational use back in 2012.

However, a new report released in November by a group of professors at Columbia University, which studied U.S. traffic fatalities between 1985 and 2014 and their relationship to medical marijuana laws, found that on average, states with medical marijuana laws had lower traffic fatality rates than those without.

Furthermore, an earlier study (2013) by professors at three universities, including the University of Colorado at Denver, found that there was an 8-11% reduction in traffic fatalities in the year following the legalization of medical marijuana.

Interestingly, while Jeff Sessions is on record suggesting marijuana use leads to an increase in heroin and cocaine use, the current attorney general Loretta Lynch admitted last September that marijuana is not a gateway drug, suggesting opioids such as Fentanyl and other painkillers are the real concern for government officials.

So, what does all of this mean for Canopy Growth shareholders? Well, there are many investment funds around the world today that are restricted from investing in tobacco-related businesses.

If the investment managers of these same funds do not face the same restrictions on marijuana-related businesses because statistics show that marijuana use — whether for recreational or medical purposes — is safer than both tobacco and alcohol use, the future demand from institutional investors could be tremendous.

In March, the first annual Institutional Capital & Cannabis Conference will take place in San Jose, California. Here, institutional investors from around the world will gather to learn how to evaluate these businesses relative to other, more traditional stocks and privately run companies.

“We are at a tipping point in this industry,” said MedMen [conference organizer] co-founder and CEO Adam Bierman in the October 24 press release. “Imagine if you had an opportunity to stake your share of the adult beverage industry just before the end of Prohibition. This is our generation’s Prohibition, and we believe wholeheartedly that it is coming to an end.”

Indeed it is — and Canopy Growth is leading the charge.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned.

More on Investing

Business man on stock market financial trade indicator background.
Tech Stocks

1 Growth Stock Down 50 Percent to Buy Right Now

There are plenty of growth stocks in the market worth considering, but Shopify (TSX:SHOP) looks like one of the best…

Read more »

You Should Know This
Dividend Stocks

How to Convert a $300 Monthly Investment Into $338 in Monthly Income

If you want a certain amount in monthly passive income, invest a similar amount today and leave the rest to…

Read more »

Increasing yield
Dividend Stocks

3 Income Stocks With Big Yields to Consider in April 2024

If you haven’t yet made your March investments, here are three income stocks to buy the dip and lock in…

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Dividend Stocks

RRSP Investors: Don’t Miss Out on This Contribution Hack!

This hack has so many benefits for you -- not just when you put it in your RRSP but for…

Read more »

edit Sale sign, value, discount
Stocks for Beginners

These 3 Growth Stocks Are on Sale and Set to Surge

Some growth stocks are on sale right now that offer massive long-term potential for investors. Here's a trio to consider…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Young woman sat at laptop by a window
Dividend Stocks

3 Dividend Stocks Everyone Should Own for the Long Haul

For investors looking for top-tier dividend stocks to buy and hold for the long term, here are three of my…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

Passive Income: 2 Safe Dividend Stocks to Own for the Next 10 Years

Dividend stocks such as Manulife and Fortis can help you generate a stable and recurring passive-income stream.

Read more »